Detalles de la búsqueda
1.
Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme.
Europace
; 22(1): 47-57, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31651951
2.
Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program.
Am Heart J
; 218: 123-127, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31806087
3.
Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry.
Am Heart J
; 198: 55-63, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29653649
4.
2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry.
Ann Noninvasive Electrocardiol
; 22(3)2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28480632
5.
Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
Europace
; 18(9): 1308-18, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27335063
6.
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation.
Am Heart J
; 167(3): 329-34, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24576516
7.
Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry.
Clin Res Cardiol
; 111(5): 548-559, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35294623
8.
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry.
Clin Res Cardiol
; 111(5): 560-573, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35294625
9.
Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program.
PLoS One
; 17(10): e0274237, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36201473
10.
Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions: the GLORIA-AF study.
Eur J Intern Med
; 91: 75-80, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34120814
11.
Anticoagulation Prescription and Outcomes in Relation to Renal Function in Patients with Atrial Fibrillation: Results from GLORIA-AF.
TH Open
; 5(1): e35-e42, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33564743
12.
Stroke prevention in atrial fibrillation changes after dabigatran availability in China: The GLORIA-AF registry.
J Arrhythm
; 36(3): 408-416, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32528565
13.
Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AF.
ESC Heart Fail
; 7(5): 2679-2689, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32613745
14.
Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up.
J Clin Med
; 9(6)2020 Jun 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32586056
15.
Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry.
Am J Cardiol
; 125(3): 383-391, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31785775
16.
Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry Program.
Am J Med
; 131(8): 945-955.e3, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29654720
17.
Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation.
J Am Coll Cardiol
; 70(13): 1573-1583, 2017 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-28935034
18.
The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.
J Am Coll Cardiol
; 69(7): 777-785, 2017 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28209218
19.
Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry.
Clin Res Cardiol
; 111(5): 593, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35384487
20.
Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry.
Thromb Haemost
; 117(12): 2376-2388, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29212125